RXi Pharmaceuticals Corporation Appoints Rolf Kiessling to its Scientific Advisory Board
February 07, 2017 at 07:02 am
RXi Pharmaceuticals Corporation announced the appointment of Dr. Rolf Kiessling, Professor in Experimental Oncology at Karolinska Institutet to its Scientific Advisory Board. Dr. Kiessling also serves as Senior Chief Physician of Radiumhemmet at Karolinska Hospital. Dr. Kiessling has broad scientific expertise in the field of experimental and clinical immunology and accredited with the discovery for Natural Killer cells (NK cells) during the mid-70's.